NeueHealth Inc. (NEUE)
6.88
0.27 (4.08%)
At close: Mar 27, 2025, 3:59 PM
NeueHealth Income Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
Revenue | 936.66M | 1.16B | 751.16M | 1.51B | 514.89M | 280.67M | 130.63M |
Cost of Revenue | 742.14M | 996.58M | 662.97M | 1.29B | 451.92M | n/a | n/a |
Gross Profit | 194.52M | 164.22M | 88.19M | 218.88M | 62.97M | 280.67M | 130.63M |
Operating Income | -102.06M | -577M | -368.76M | -343.63M | -170.38M | -125.34M | -62.64M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -99.46M | -629.17M | -381.58M | -349.63M | -170.38M | -125.34M | -62.64M |
Net Income | -134.68M | -1.15B | -1.46B | -1.18B | -248.44M | -125.34M | -62.64M |
Selling & General & Admin | 273.9M | 259.16M | 315.11M | 465.48M | 203.53M | 180.49M | 95.84M |
Research & Development | n/a | n/a | n/a | n/a | 19.43M | n/a | n/a |
Other Expenses | 28.03M | 482.06M | 784K | 1.23M | -413.12M | -181.02M | -96.87M |
Operating Expenses | 301.93M | 741.22M | 385.16M | 562.5M | 233.35M | 181.02M | 96.87M |
Interest Expense | 18.7M | 38.2M | 12.82M | 7.23M | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 82.34M | 76.92M | 34.56M | n/a | n/a |
Cost & Expenses | 1.04B | 1.75B | 1.05B | 1.86B | 685.27M | -405.41M | -193.27M |
Income Tax | 2.6M | -1.43M | 3.66M | -26.52M | -9.16M | n/a | n/a |
Shares Outstanding (Basic) | 8.23M | 7.95M | 7.87M | 4.9M | 7.69M | 7.82M | 7.82M |
Shares Outstanding (Diluted) | 8.23M | 7.95M | 7.87M | 4.9M | 7.69M | 7.82M | 7.82M |
EPS (Basic) | -16.37 | -150.94 | -185 | -241.66 | -32.3 | -16.03 | -8.01 |
EPS (Diluted) | -16.37 | -150.94 | -185 | -241.66 | -32.3 | -16.03 | -8.01 |
EBITDA | -65.11M | -566.8M | -246.39M | -308.58M | -249.31M | -124.2M | -61.61M |
Depreciation & Amortization | 15.65M | 18.3M | 30.71M | 35.05M | 8.29M | 1.13M | 1.03M |